CDC Leadership: Who’s in Charge Now?
The CDC’s leadership structure is in disarray, creating ripples of uncertainty around vaccine policy and fueling potential legal battles. With no confirmed director, Robert F. Kennedy Jr. appears to be exerting important influence, causing a stir among health experts nationwide. This situation raises serious questions about the current vaccine recommendations,impacting public health directives and fueling public concern. Recent decisions, such as banning thimerosal from certain flu vaccines, amplify the need for resolved CDC leadership and stricter adherence to vaccine policy. Conflicting reports of who’s in charge and a lack of clarity continue to add to the confusion. Explore the impact of these decisions on public health with the latest updates from News Directory 3. Discover what’s next …
CDC Leadership Vacuum Raises Concerns Over Vaccine Policy
Updated June 29, 2025
The Centers for Disease Control and Prevention (CDC) faces a leadership quandary, creating confusion and potential legal challenges. While no confirmed or acting director is in place, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. appears to be exerting considerable control over the agency, influencing vaccine recommendations.
Paul Offit, a pediatrics professor at the University of Pennsylvania, stated that Kennedy essentially acts as the CDC director. Renée Landers, a health law professor at Suffolk University, echoed this concern, noting Kennedy’s increased ability to influence decisions.
Recent actions have heightened anxieties. Autonomous vaccine advisers appointed by kennedy voted to ban thimerosal from 4% of flu vaccines, despite its proven safety record. this decision,critics say,could limit access to flu vaccines. Kennedy also softened COVID-19 vaccine recommendations for children and ended them for pregnant individuals, contradicting scientific evidence.
Landers expressed concern that this power vacuum allows Kennedy to make decisions inconsistent with scientific consensus.The situation is further complicated by conflicting accounts of who is leading the CDC. Kennedy testified before a Senate committee that Matt Buzzelli, the CDC’s chief of staff, had replaced susan Monarez as acting director. Though, experts dispute this claim, asserting that Buzzelli does not meet the requirements for the position.
The lack of clarity, coupled with past non-compliance with reporting requirements, raises the specter of legal challenges. Actions taken by individuals without proper authority could be vulnerable to lawsuits,notably concerning contracts with state and local governments,according to Landers.
Congress introduced a law in 2023 mandating Senate confirmation for CDC directors, marking the first time the agency head has undergone this process. David Weldon’s nomination was withdrawn shortly before his confirmation hearing, and while Susan Monarez testified before the Senate, a vote on her nomination remains uncertain.
Anne Joseph O’Connell, a professor at Stanford Law School, explained that the Federal Vacancies Reform Act typically elevates duties to the agency head during a vacancy. However, she noted that in this case, many people distrust the secretary on these matters.
andrew Nixon, HHS director of communications, told Stat News that Buzzelli is carrying out some duties of the CDC Director as the Senior Official, as necessary, and is surrounded by highly qualified medical professionals and advisors to help fulfill these duties as appropriate.
what’s next
The Senate’s decision on Susan Monarez’s nomination will be critical in resolving the leadership void at the CDC and addressing concerns about vaccine policy decisions.